NASDAQ · Biotechnology

Tango Therapeutics, Inc. (TNGX) Stock

$23.92 +5.98% NASDAQ: TNGX Healthcare

Valuation

MetricValue
Price$23.92
Market Cap$3.89B
P/E Ratio-27.34
P/B Ratio3.40
P/S Ratio70.32
EPS (TTM)$-0.87
52-Week High$34.39
52-Week Low$6.69
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.74%
ROA-11.52%
ROCE-12.94%
Gross Margin-180.65%
Operating Margin-179.03%
Net Margin-229.92%
Debt/Equity0.03
Current Ratio16.09

Annual Financials (USD)

Metric20212022202320242025
Revenue$37.0M$25.0M$37.0M$42.0M$62.0M
Operating Profit$-58.0M$-111.0M$-114.0M$-146.0M$-111.0M
Net Profit$-58.0M$-108.0M$-102.0M$-130.0M$-102.0M
EPS$-0.94$-1.23$-1.08$-1.19$-0.87
Op Margin-157.1%-446.8%-312.6%-346.1%-178.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$500.0M$436.0M$403.0M$316.0M$399.0M
Total Liabilities$155.0M$187.0M$149.0M$117.0M$53.0M
Cash$143.0M$60.0M$66.0M$70.0M$112.0M
Borrowings$2.0M$41.0M$39.0M$36.0M$34.0M

Latest News

How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48% Zacks · Jul 22, 2026 Mizuho Raises Price Target on Tango Therapeutics to $40 From $36, Keeps Outperform Rating MT Newswires · Jul 17, 2026 Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues Insider Monkey · Jul 15, 2026 2 Monster Growth Stocks Analysts Think Can Reach New Highs TipRanks · Jul 9, 2026 Tango Therapeutics Rides a New Precision Oncology Trend in 2026 Zacks · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-60.0M$-109.0M$-118.0M$-132.0M$-139.0M
Investing Cash Flow$-185.0M$19.0M$40.0M$85.0M$-42.0M
Financing Cash Flow$-15.0M$2.0M$2.0M$6.0M$0
Net Cash Flow$114.0M$-81.0M$6.0M$2.0M$43.0M
Free Cash Flow$-61.0M$-117.0M$-120.0M$-132.0M$-140.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.69
EV / EBITDA-28.38
FCF Yield-3.81%
Quick Ratio50.82
Interest Coverage0.00
Return 1Y242.23%
Return 3Y224.62%
Return 5Y101.25%

Ownership

Insiders Held1.17%
Institutions Held114.42%
Institutions Float Held115.78%
Institutional HolderSharesReport Date
RTW Investments LP13,300,6202026-03-31
Adage Capital Partners GP L.L.C.12,809,4852026-03-31
Boxer Capital Management, LLC10,876,2192026-03-31
TCG Crossover Management, LLC10,531,0712026-03-31
FMR, LLC9,905,9192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRVAcrivon Therapeutics, Inc. $1.93 +2.94% -1.12 $82.39M 0.00%
CCCCC4 Therapeutics, Inc. $3.05 +7.02% -2.95 $337.23M 0.00%
ERASErasca, Inc. $15.62 +1.03% -15.52 $5.42B 0.00%
FHTXFoghorn Therapeutics Inc. $2.04 +2.51% -2.11 $119.78M 0.00%
IDYAIDEAYA Biosciences, Inc. $36.19 +0.36% -19.46 $3.44B 0.00%

About Tango Therapeutics, Inc.

Tango Therapeutics, Inc. (TNGX) stock trades at $23.92 with a market capitalization of $3.89B. The stock is valued at a price-to-earnings (P/E) ratio of -27.34, price-to-book of 3.40, price-to-sales of 70.32. Over the past 52 weeks the stock has ranged between $6.69 and $34.39, and currently trades 30.4% below its 52-week high.

On profitability, Tango Therapeutics, Inc. generates a return on equity (ROE) of -25.74%, return on capital employed of -12.94%, an operating margin of -179.03%, a net profit margin of -229.92%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1176.71 +0.61% JNJ Johnson & Johnson $261.15 +1.82% ABBV AbbVie Inc. $277.39 +1.82% MRK Merck & Company, Inc. Common Stock (new) $146.33 +2.77% UNH UnitedHealth Group Incorporated Common Stock (DE) $377.90 +1.87% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $660.09 +1.24% AMGN Amgen Inc. $415.61 +2.01% GILD Gilead Sciences, Inc. $151.12 +2.73% ABT Abbott Laboratories $99.16 +0.68% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides